YCBD — cbdMD Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual income statement for cbdMD, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	41.9	44.5	35.4	24.2	19.5
Cost of Revenue
Gross Profit	26.4	30	22.3	15	12
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	30.4	69.3	106	46.5	22.7
Operating Profit	11.4	-24.8	-70.4	-22.3	-3.24
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	11.3	-24.3	-70.1	-22.9	-3.7
Provision for Income Taxes
Net Income After Taxes	12.7	-23.4	-70.1	-22.9	-3.7
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	12.6	-23.4	-70.1	-22.9	-3.7
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	12.2	-25.9	-74.1	-26.9	-7.7
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-6.55	-18.5	-15.9	-6.88	-1.8